201008_S_AT |
TXNIP |
thioredoxin interacting protein |
201041_S_AT |
DUSP1 |
dual specificity phosphatase 1 |
201416_AT |
SOX4 |
SRY (sex determining region Y)-box 4 |
201502_S_AT |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
201976_S_AT |
MYO10 |
myosin X |
202435_S_AT |
CYP1B1 |
cytochrome P450, family 1, subfamily B, polypeptide 1 |
202436_S_AT |
CYP1B1 |
cytochrome P450, family 1, subfamily B, polypeptide 1 |
202437_S_AT |
CYP1B1 |
cytochrome P450, family 1, subfamily B, polypeptide 1 |
202670_AT |
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
202887_S_AT |
DDIT4 |
DNA-damage-inducible transcript 4 |
203140_AT |
BCL6 |
B-cell CLL/lymphoma 6 (zinc finger protein 51) |
203304_AT |
BAMBI |
BMP and activin membrane-bound inhibitor homolog (Xenopus laevis) |
203373_AT |
SOCS2 |
suppressor of cytokine signaling 2 |
203542_S_AT |
KLF9 |
Kruppel-like factor 9 |
203543_S_AT |
KLF9 |
Kruppel-like factor 9 |
203685_AT |
BCL2 |
B-cell CLL/lymphoma 2 |
203947_AT |
CSTF3 |
cleavage stimulation factor, 3' pre-RNA, subunit 3, 77kDa |
207980_S_AT |
CITED2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
208763_S_AT |
TSC22D3 |
TSC22 domain family, member 3 |
208937_S_AT |
ID1 |
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein |
209121_X_AT |
NR2F2 |
nuclear receptor subfamily 2, group F, member 2 |
209184_S_AT |
IRS2 |
insulin receptor substrate 2 |
209185_S_AT |
IRS2 |
insulin receptor substrate 2 |
209373_AT |
MALL |
mal, T-cell differentiation protein-like |
212154_AT |
SDC2 |
syndecan 2 |
212501_AT |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
213139_AT |
SNAI2 |
snail homolog 2 (Drosophila) |
213295_AT |
CYLD |
cylindromatosis (turban tumor syndrome) |
218041_X_AT |
SLC38A2 |
solute carrier family 38, member 2 |
219657_S_AT |
KLF3 |
Kruppel-like factor 3 (basic) |
220924_S_AT |
SLC38A2 |
solute carrier family 38, member 2 |